In 2020, Lida et al. illustrated that luteolin reduced the viability of T24 BC cells and induced G2/M cell-cycle arrest by increasing p21 and TRX1 and inhibiting p-S6 expression, which plays a crucial role in regulating the mTOR signaling pathway. Here, MTOR is linked to breast cancer.